Reinert T - Search Results

1

Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors.

Werutsky G, Reinert T, Rosa ML, Barrios CH. Werutsky G, et al. Among authors: reinert t. Clin Breast Cancer. 2021 Dec;21(6):e688-e692. doi: 10.1016/j.clbc.2021.04.003. Epub 2021 Apr 20. Clin Breast Cancer. 2021. PMID: 33992526 Review.

2

Optimal management of hormone receptor positive metastatic breast cancer in 2016.

Reinert T, Barrios CH. Reinert T, et al. Ther Adv Med Oncol. 2015 Nov;7(6):304-20. doi: 10.1177/1758834015608993. Ther Adv Med Oncol. 2015. PMID: 26557899 Free PMC article. Review.

3

Definition of First-Line Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer.

Reinert T, Barrios CH. Reinert T, et al. J Clin Oncol. 2016 Jun 1;34(16):1959-60. doi: 10.1200/JCO.2015.66.0803. Epub 2016 Mar 21. J Clin Oncol. 2016. PMID: 27001564 No abstract available.

4

Multidisciplinary Approach to Neoadjuvant Endocrine Therapy in Breast Cancer: A Comprehensive Review.

Reinert T, Ramalho S, Gonçalves R, Barrios CH, Graudenz MS, Bines J. Reinert T, et al. Rev Bras Ginecol Obstet. 2016 Dec;38(12):615-622. doi: 10.1055/s-0036-1597579. Epub 2016 Dec 21. Rev Bras Ginecol Obstet. 2016. PMID: 28002848 Free PMC article. Review.

5

Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer.

Reinert T, Saad ED, Barrios CH, Bines J. Reinert T, et al. Front Oncol. 2017 Mar 15;7:26. doi: 10.3389/fonc.2017.00026. eCollection 2017. Front Oncol. 2017. PMID: 28361033 Free PMC article. Review.

6

Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System.

Debiasi M, Reinert T, Kaliks R, Amorim G, Caleffi M, Sampaio C, Fernandes GDS, Barrios CH. Debiasi M, et al. Among authors: reinert t. J Glob Oncol. 2016 Jul 20;3(3):201-207. doi: 10.1200/JGO.2016.005678. eCollection 2017 Jun. J Glob Oncol. 2016. PMID: 28717761 Free PMC article.

7

Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer.

Reinert T, Debiasi M, Bines J, Barrios CH. Reinert T, et al. Breast Cancer Res Treat. 2018 Apr;168(2):457-465. doi: 10.1007/s10549-017-4593-x. Epub 2017 Nov 30. Breast Cancer Res Treat. 2018. PMID: 29190006 Review.

8

Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review.

Reinert T, Barrios CH. Reinert T, et al. Ther Adv Med Oncol. 2017 Nov;9(11):693-709. doi: 10.1177/1758834017728928. Epub 2017 Sep 8. Ther Adv Med Oncol. 2017. PMID: 29344106 Free PMC article. Review.

9

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.

Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O. Debiasi M, et al. Among authors: reinert t. Front Oncol. 2018 May 22;8:156. doi: 10.3389/fonc.2018.00156. eCollection 2018. Front Oncol. 2018. PMID: 29872641 Free PMC article. Review.

10

Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer.

Reinert T, de Paula B, Shafaee MN, Souza PH, Ellis MJ, Bines J. Reinert T, et al. Chin Clin Oncol. 2018 Jun;7(3):25. doi: 10.21037/cco.2018.06.06. Chin Clin Oncol. 2018. PMID: 30056727 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters